Long‐term outcomes and risk profile of c<scp>T</scp>3<scp>N</scp>0 breast cancer treated with neoadjuvant chemotherapy and curative surgery
Patients with cT3N0 breast cancer classified for rigorous pretreatment evaluation and treated with NAC and radical surgery had favourable oncological outcomes. A clinical risk group based on clinical and immunohistochemical risk factors was an excellent predictor of survival and recurrence.
Authors
- Jinhong Jung (ORCID: https://orcid.org/0000-0002-7034-8454)
- Byung Ho Son (ORCID: https://orcid.org/0000-0002-6757-0388)
- Young Seob Shin (ORCID: https://orcid.org/0000-0002-5544-9492)
- Su Ssan Kim (ORCID: https://orcid.org/0000-0002-8473-302X)
- Il Yong Chung (ORCID: https://orcid.org/0000-0001-5271-8530)
- Seung Do Ahn (ORCID: https://orcid.org/0000-0003-4153-4191)
- Jong Won Lee (ORCID: https://orcid.org/0000-0002-2203-3634)
- Jae Ho Jeong (ORCID: https://orcid.org/0000-0002-8749-2612)
- Jaeha Lee (ORCID: https://orcid.org/0009-0000-4152-9945)
Institutions
- Ulsan College (KR)
- Asan Medical Center (KR)
- University of Ulsan (KR)
Publication Details
- Journal
- Journal of Medical Imaging and Radiation Oncology
- Published
- 2024-09-09
- DOI
- https://doi.org/10.1111/1754-9485.13746
- Primary Topic
- Breast Cancer Treatment Studies
- Type
- article
- Field-Weighted Citation Impact
- 0.00